DCM Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,662
Closed -$755K 106
2022
Q3
$755K Buy
+1,662
New +$795K 0.38% 66
2022
Q2
Sell
-2,105
Closed -$1.03M 204
2022
Q1
$1.03M Buy
2,105
+776
+58% +$355K 0.37% 74
2021
Q4
$616K Buy
+1,329
New +$559K 0.18% 125

Other funds holding ELV

DCM Advisors's ELV Position: Q4 2022 in Review

DCM Advisors sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 1,662 shares — an estimated $755K sold.

DCM Advisors first reported a position in ELV in Q4 2021 and held it in 3 quarters. The position peaked at $1.03M in Q1 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • DCM Advisors reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • DCM Advisors sold 1,662 Elevance Health shares in Q4 2022, an estimated $755K.
  • DCM Advisors first reported a position in Elevance Health in Q4 2021 and held it in 3 quarters.
  • DCM Advisors's Elevance Health position peaked at $1.03M in Q1 2022.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on DCM Advisors's 13F filing for Q4 2022, filed 11 Sep 2023.